Article
Long-term outcome of telbivudine versus entecavir in treating higher viral load chronic hepatitis B patients without cirrhosis.
Journal of viral hepatitis - 1 Nov 2017
Pan H-Y, Pan H-Y, Song W-Y, Zheng W, Tong Y-X, Yang D-H, Dai Y-N, Chen M-J, Wang M-S, Huang Y-C, Zhang J-J, Huang H-J
Abstract excerpt
Chronic hepatitis B (CHB) patients with higher hepatitis B virus (HBV) load (higher viral load [HVL], HBV DNA ≥1 × 107 copies/mL) require antiviral therapy, but data for evaluating the long-term outcome of this therapy with antiviral agents remain limited. We comparatively evaluated the efficacy and the safety of nucleoside analogues in 179 noncirrhotic CHB patients with HVL over 5 years. The HBeAg-positive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.